01.09.2014 Views

Anaesthesia, Intensive Care and Pain Medicine - St Vincent's ...

Anaesthesia, Intensive Care and Pain Medicine - St Vincent's ...

Anaesthesia, Intensive Care and Pain Medicine - St Vincent's ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Department of Metabolism<br />

<strong>St</strong>.Vincent’s Healthcare Group<br />

Department of<br />

Medical Oncology<br />

Departmental Review<br />

108<br />

compliance with Clinical Pathology Accreditation (CPA )<br />

requirements.<br />

Representative Functions<br />

Barbara Murray is a member of the Executive Committee of<br />

Eurachem Irel<strong>and</strong>.<br />

Meetings attended by Department Personnel<br />

Roche 2nd Irel<strong>and</strong> User Group Forum<br />

Dublin,27th – 29th May 2003<br />

Nutrition Society Meeting ( Optimal Nutrition for Osteoporosis<br />

Prevention )<br />

Cork,18th – 20th June 2003<br />

Irish Endocrine Society<br />

Armagh, 7th – 8th November 2003<br />

Annual Conference of the Association of Clinical Biochemists<br />

Malahide, 14th – 15th November 2003<br />

Publications<br />

Suliman AM, Freaney R,Smith TP, McBrinn Y, Murray B, McKenna<br />

TJ. The Impact of Different Glucocorticoid Replacement schedules<br />

on Bone Turnover <strong>and</strong> Insulin Sensitivity in Patients with Adrenal<br />

Insufficiency.<br />

Clin Endocrinol (Oxf) 2003 59(3): 380-87<br />

Murphy E,Freaney R,Bresnihan B, McKenna M, Fitzgerald O.<br />

Increased Bone Resorption <strong>and</strong> Failure to Respond to Antiresorptive<br />

Therapy in Progressive Dystrophic Calcification.<br />

Calcif Tissue Int.2003 Nov;73(5) :433-40<br />

Abstract<br />

Smith D, Murray B, Gibney J, McKenna TJ.<br />

Application of new Indices of Bone activity for evaluation of the<br />

response to treatment of Hyperthyroidism <strong>and</strong> Paget’s Disease.<br />

Ir. J.Med. Sci.2003;172(4):17<br />

2003 was a highly successful period of growth for the Medical<br />

Oncology Department of <strong>St</strong>.Vincent’s Healthcare Group. As<br />

before, patient activities were concentrated in the <strong>St</strong>.Anne’s<br />

Ward complex.As is the case throughout the medical oncology<br />

world,increasing the focus of acute cancer therapeutics in the<br />

ambulatory setting,<strong>and</strong> the oncology day ward / outpatients<br />

area,continued to provide a high quality service, to increasing<br />

numbers of cancer patients.<br />

Research protocols resumed in the division in the Summer of<br />

2003. The flagship clinical trials from the breast programme<br />

remained the BCIRG 006 <strong>and</strong> 007 studies,both of which<br />

neared the completion of their accrual during 2003.Both these<br />

studies are chaired/co-chaired by <strong>St</strong>.Vincent’s investigators.<br />

On the educational front,post-clinic teaching conferences are<br />

held approximately twice per week.<br />

Professor Crown was awarded the Thomas Baldwin Chair in<br />

Translational Cancer Research by Dublin City University, in<br />

recognition of an ongoing research affiliation between <strong>St</strong>.<br />

Vincent’s <strong>and</strong> that institution, which complements our existing<br />

relationships with University College Dublin.Research projects<br />

in drug resistance conducted by Dr. Michael O’Leary reached<br />

their completion during 2003. Ms Brigid Browne commenced<br />

work as a doctoral student in the area of HER-2 biology, jointly<br />

in DCU <strong>and</strong> UCLA.Professor Crown was elected to the<br />

Educational Committee of the American Society of Clinical<br />

Oncology.<br />

Meetings<br />

In 2003,Professor Crown lectured or presented at the Post San<br />

Antonio meeting for German Gynaecologists,Munich;the Miami<br />

Breast Cancer Conference;Anglo Celtic meetings,London,<br />

Sheffield & Leuven;Various Aventis Advisory Board Meetings;<br />

Herceptin meeting,Dublin;ESGO Congress,Brussels; Oncology<br />

Speakers Bureau,L.A.,New York <strong>and</strong> Chicago;ASCO, Chicago;<br />

ASCO Education Committee Meeting,Chicago;ECCO,<br />

Copenhagen;Austrian Society of Surgical Oncology meeting,<br />

Vienna;Third International Symposium on Translational<br />

Research,California;Breast Cancer Symposium,New Jersey;<br />

ICORG <strong>St</strong>rategy Meeting;Annual San Antonio Breast Cancer<br />

Symposium,December.<br />

Abstracts 2003<br />

Crown J, Leyvraz S,Verrill M,Guillem V, Efremedis A, Garcia<br />

Conde-Bru J, Welsh R, Montes A,Leonard R,Baselga J.<br />

Superiority of T<strong>and</strong>em High-Dose (HDC) Over Conventionally-<br />

Dosed Chemotherapy (CDC) in Patients (Pts) with Metastatic<br />

Breast Cancer (MBC):Updated Results of the International<br />

R<strong>and</strong>omised Breast Cancer Dose-Intensity <strong>St</strong>udy (IBDIS).Ann<br />

Meet Am Soc Clin Onco 22:88,2003.<br />

Crown J, Leyvraz S,Verrill M,Guillem V, Efremedis A, Garcia-<br />

Conde-Bru J, Welsh R, Montes A,Leonard R,Baselga J.<br />

Superiority of T<strong>and</strong>em High-Dose Over conventionally-dosed<br />

Chemotherapy in Patients with Metastatic Breast Cancer:<br />

Updated Results of the International R<strong>and</strong>omised Breast Cancer<br />

Dose-Intensity <strong>St</strong>udy (IBDIS).Eur J Can Supp 1: 5,S134,2003.<br />

Donnellan P, Crown J, Hall W. HTLV seroprevalence in Irish<br />

populations is low.Ann Meet Am Soc Clin Onco 22: 3 5 5 1 ,2 0 0 3 .<br />

Publications 2003<br />

O’Donovan N, Crown J,<strong>St</strong>unell H, Hill AD, McDermott E,<br />

O’Higgins N,Duffy MJ. Caspase 3 in breast cancer. Clin Cancer<br />

Res.2003 Feb;9(2):738-42.<br />

Ballot J,McDonnell D, Crown J. Successful treatment of<br />

thrombocytopenia due to marrow metastases of breast cancer with<br />

weekly docetaxel. J Natl Cancer Inst.2003 Jun 4;95(11):831-2.<br />

Crown J, Pegram M. Platinum-taxane combinations in metastatic<br />

breast cancer: an evolving era of molecularly targeted therapy.<br />

Breast Cancer Res Treat.2003; 79 Suppl 1:S11-8.Review.<br />

Crown J. Chemotherapy dose <strong>and</strong> schedule in adjuvant treatment<br />

of breast cancer: phoenix,turkey or dodo? Lancet 2003 Aug 30;<br />

362(9385):677-8.<br />

109

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!